Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex

Cerebral Cortex

Volumn 18, Issue 11, 2008, Pages 2560-2573

  Henson, Maile A ^a   Roberts, Adam C ^a,b   Salimi, Kayvon ^b   Vadlamudi, Swarooparani ^b   Hamer, Robert M ^a,b,c   Gilmore, John H ^a,b   Jarskog, L Fredrik ^d,e   Philpot, Benjamin D ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Antipsychotic; DLPFC; Glutamate; Postmortem; Schizophrenia

Indexed keywords

MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3A; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG;

ADOLESCENCE; ADOLESCENT; ADULT; ADULTHOOD; ANIMAL TISSUE; ARTICLE; BIRTH; C57BL 6 MOUSE; CALCIUM TRANSPORT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC SPINE; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MALE; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SCHIZOPHRENIA; SPRAGUE DAWLEY RAT; SYNAPSE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIPSYCHOTIC AGENTS; CHILD; CHILD, PRESCHOOL; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 50449086802     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhn017     Document Type: Article

References (132)

1. Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP, Potkin SG, Sandman CA, Bunney WE, Jr, Jones EG. 1996. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci. 16:19-30.
2. Al-Hallaq RA, Jarabek BR, Fu Z, Vicini S, Wolfe BB, Yasuda RP. 2002. Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2 subunits. Mol Pharmacol. 62:1119-1127.
3. Anderson SA, Classey JD, Conde F, Lund JS, Lewis DA. 1995. Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience. 67:7-22.
4. Andersson O, Stenqvist A, Attersand A, von Euler G. 2001. Nucleotide sequence, genomic organization, and chromosomal localization of genes encoding the human NMDA receptor subunits NR3A and NR3B. Genomics. 78:178-184.
5. Awobuluyi M, Lipton SA, Sucher NJ. 2003. Translationally distinct populations of NMDA receptor subunit NR1 mRNA in the developing rat brain. J Neurochem. 87:1066-1075.
6. Babb TL, Mikuni N, Najm I, Wylie C, Olive M, Dollar C, MacLennan H. 2005. Pre- and postnatal expressions of NMDA receptors 1 and 2B subunit proteins in the normal rat cortex. Epilepsy Res. 64:23-30.
7. Bendel O, Meijer B, Hurd Y, von Euler G. 2005. Cloning and expression of the human NMDA receptor subunit NR3B in the adult human hippocampus. Neurosci Lett. 377:31-36.
8. Bourgeois JP, Goldman-Rakic PS, Rakic P. 1994. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex. 4:78-96.
9. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. 2001. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res. 49:171-178.
10. Bressan RA, Erlandsson K, Stone JM, Mulligan RS, Krystal JH, Ell PJ, Pilowsky LS. 2005. Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo. Biol Psychiatry. 58:41-46.
11. Brody SA, Nakanishi N, Tu S, Lipton SA, Geyer MA. 2005. A developmental influence of the N-methyl-D-aspartate receptor NR3A subunit on prepulse inhibition of startle. Biol Psychiatry. 57:1147-1152.
12. Brose N, Gasic GP, Vetter DE, Sullivan JM, Heinemann SF. 1993. Protein chemical characterization and immunocytochemical localization of the NMDA receptor subunit NMDA R1. J Biol Chem. 268:22663-22671.
13. Castle DJ, Murray RM. 1991. The neurodevelopmental basis of sex differences in schizophrenia. Psychol Med. 21:565-575.
14. Chan SF, Sucher NJ. 2001. An NMDA receptor signaling complex with protein phosphatase 2A. J Neurosci. 21:7985-7992.
15. Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, Shin Y, Cui J, Tu S, Sevarino KA, Nakanishi N, et al. 2002. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 415:793-798.
16. Chen L, Cooper NG, Mower GD. 2000. Developmental changes in the expression of NMDA receptor subunits (NR1, NR2A, NR2B) in the cat visual cortex and the effects of dark rearing. Brain Res Mol Brain Res. 78:196-200.
17. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:623-634.
18. Ciabarra AM, Sullivan JM, Gahn LG, Pecht G, Heinemann S, Sevarino KA. 1995. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci. 15:6498-6508.
19. Clinton SM, Haroutunian V, Meador-Woodruff JH. 2006. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia. J Neurochem. 98:1114-1125.
20. Coyle JT, Tsai G, Goff D. 2003. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci. 1003:318-327.
21. Cull-Candy S, Brickley S, Farrant M. 2001. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol. 11:327-335.
22. Cull-Candy SG, Leszkiewicz DN. 2004. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE. 255:re16.
23. Czaja K, Ritter RC, Burns GA. 2006. N-methyl-D-aspartate receptor subunit phenotypes of vagal afferent neurons in nodose ganglia of the rat. J Comp Neurol. 496:877-885.
24. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, Dikkes P, Conner DA, Rayudu PV, Cheung W, et al. 1998. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature. 393:377-381.
25. de Graaf-Peters VB, Hadders-Algra M. 2006. Ontogeny of the human central nervous system: what is happening when? Early Hum Dev. 82:257-266.
26. Durand GM, Kovalchuk Y, Konnerth A. 1996. Long-term potentiation and functional synapse induction in developing hippocampus. Nature. 381:71-75.
27. Durstewitz D, Gabriel T. 2007. Dynamical basis of irregular spiking in NMDA-driven prefrontal cortex neurons. Cereb Cortex. 17:894-908.
28. Eriksson M, Nilsson A, Froelich-Fabre S, Akesson E, Dunker J, Seiger A, Folkesson R, Benedikz E, Sundstrom E. 2002. Cloning and expression of the human N-methyl-D-aspartate receptor subunit NR3A. Neurosci Lett. 321:177-181.
29. Fernandez-Monreal M, Lopez-Atalaya JP, Benchenane K, Cacquevel M, Dulin F, Le Caer JP, Rossier J, Jarrige AC, Mackenzie ET, Colloc'h N, et al. 2004. Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling. J Biol Chem. 279:50850-50856.
30. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EJ. 1995. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci. 15:2453-2461.
31. Folkerth RD, Haynes RL, Borenstein NS, Belliveau RA, Trachtenberg F, Rosenberg PA, Volpe JJ, Kinney HC. 2004. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol. 63:990-999.
32. Forrest D, Yuzaki M, Soares HD, Ng L, Luk DC, Sheng M, Stewart CL, Morgan JI, Connor JA, Curran T. 1994. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron. 13:325-338.
33. Frankle WG, Lerma J, Laruelle M. 2003. The synaptic hypothesis of schizophrenia. Neuron. 39:205-216.
34. Gallagher MJ, Huang H, Lynch DR. 1998. Modulation of the N-methyl-D-aspartate receptor by haloperidol: NR2B-specific interactions. J Neurochem. 70:2120-2128.
35. Gallinat J, Gotz T, Kalus P, Bajbouj M, Sander T, Winterer G. 2007. Genetic variations of the NR3A subunit of the NMDA receptor modulate prefrontal cerebral activity in humans. J Cogn Neurosci. 19:59-68.
36. Gazzaley AH, Weiland NG, McEwen BS, Morrison JH. 1996. Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J Neurosci. 16:6830-6838.
37. Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM, Mardis ER, et al. 2007. Evolutionary and biomedical insights from the rhesus macaque genome. Science. 316:222-234.
38. Glantz LA, Gilmore JH, Hamer RM, Lieberman JA, Jarskog LF. 2007. Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood. Neuroscience. 149:582-591.
39. Glantz LA, Lewis DA. 2000. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 57:65-73.
40. Goebel DJ, Poosch MS. 1999. NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A. Brain Res Mol Brain Res. 69:164-170.
41. Goldman-Rakic PS. 1995. Cellular basis of working memory. Neuron. 14:477-485.
42. Gonzalez-Burgos G, Kroener S, Zaitsev AV, Povysheva NV, Krimer LS, Barrionuevo G, Lewis DA. 2007. Functional maturation of excitatory synapses in layer 3 pyramidal neurons during postnatal development of the primate prefrontal cortex. Cereb Cortex. doi:10.1093 cercor/bhm095.
43. Hanaoka T, Toyoda H, Mizuno T, Kikuyama H, Morimoto K, Takahata R, Matsumura H, Yoneda H. 2003. Alterations in NMDA receptor subunit levels in the brain regions of rats chronically administered typical or atypical antipsychotic drugs. Neurochem Res. 28:919-924.
44. Haynes RL, Borenstein NS, Desilva TM, Folkerth RD, Liu LG, Volpe JJ, Kinney HC. 2005. Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol. 484:156-167.
45. Huttenlocher PR. 1979. Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res. 163:195-205.
46. Huttenlocher PR, Dabholkar AS. 1997. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol. 387:167-178.
47. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. 1999. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 283:70-74.
48. Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM. 1996. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol Pharmacol. 50:1541-1550.
49. Isaac JT, Crair MC, Nicoll RA, Malenka RC. 1997. Silent synapses during development of thalamocortical inputs. Neuron. 18:269-280.
50. Ishihama K, Turman JE, Jr. 2006. NR3 protein expression in trigeminal neurons during postnatal development. Brain Res. 1095:12-16.
51. Jarskog LF, Gilmore JH, Glantz LA, Gable KL, German TT, Tong RI, Lieberman JA. 2007. Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. Neuropsychopharmacology. 32:95-102.
52. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH. 2004. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry. 161:109-115.
53. Javitt DC, Zukin SR. 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 148:1301-1308.
54. Jentsch JD, Roth RH. 1999. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 20:201-225.
55. Komuro H, Rakic P. 1993. Modulation of neuronal migration by NMDA receptors. Science. 260:95-97.
56. Kristiansen LV, Beneyto M, Haroutunian V, Meador-Woodruff JH. 2006. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol Psychiatry. 11:705,737-747.
57. Kristiansen LV, Huerta I, Beneyto M, Meador-Woodruff JH. 2007. NMDA receptors and schizophrenia. Curr Opin Pharmacol. 7:48-55.
58. Lack AK, Floyd DW, McCool BA. 2005. Chronic ethanol ingestion modulates proanxiety factors expressed in rat central amygdala. Alcohol. 36:83-90.
59. Laurie DJ, Bartke I, Schoepfer R, Naujoks K, Seeburg PH. 1997. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res Mol Brain Res. 51(1-2):23-32.
60. Law AJ, Weickert CS, Webster MJ, Herman MM, Kleinman JE, Harrison PJ. 2003. Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation. Eur J Neurosci. 18:1197-1205.
61. Leveque JC, Macias W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S, Li XM, Coyle JT, Huganir RL, Heckers S, et al. 2000. Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci. 20:4011-4020.
62. Lewis DA. 1997. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology. 16:385-398.
63. Lewis DA, Levitt P. 2002. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci. 25:409-432.
64. Li L, Yun SH, Keblesh J, Trommer BL, Xiong H, Radulovic J, Tourtellotte WG. 2007. Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory. Mol Cell Neurosci. 35:76-88.
65. Lipton SA, Nakanishi N. 1999. Shakespeare in love - with NMDA receptors? Nat Med. 5:270-271.
66. Lisman JE, Fellous JM, Wang XJ. 1998. A role for NMDA-receptor channels in working memory. Nat Neurosci. 1:273-275.
67. Luo J, Bosy TZ, Wang Y, Yasuda RP, Wolfe BB. 1996. Ontogeny of NMDA R1 subunit protein expression in five regions of rat brain. Brain Res Dev Brain Res. 92:10-17.
68. Magnusson KR, Bai L, Zhao X. 2005. The effects of aging on different C-terminal splice forms of the zeta1(NR1) subunit of the N-methyl-d-aspartate receptor in mice. Brain Res Mol Brain Res. 135:141-149.
69. Malenka RC, Bear MF. 2004. LTP and LTD: an embarrassment of riches. Neuron. 44:5-21.
70. Malenka RC, Nicoll RA. 1999. Long-term potentiation - a decade of progress? Science. 285:1870-1874.
71. Matsuda K, Fletcher M, Kamiya Y, Yuzaki M. 2003. Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors. J Neurosci. 23:10064-10073.
72. May P, Rohlmann A, Bock HH, Zurhove K, Marth JD, Schomburg ED, Noebels JL, Beffert U, Sweatt JD, Weeber EJ, et al. 2004. Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol Cell Biol. 24:8872-8883.
73. McEwen B. 2002. Estrogen actions throughout the brain. Recent Prog Horm Res. 57:357-384.
74. Mimmack ML, Brooking J, Bahn S. 2004. Quantitative polymerase chain reaction: validation of microarray results from postmortem brain studies. Biol Psychiatry. 55:337-345.
75. Miyamoto Y, Chen L, Sato M, Sokabe M, Nabeshima T, Pawson T, Sakai R, Mori N. 2005. Hippocampal synaptic modulation by the phosphotyrosine adapter protein ShcC/N-Shc via interaction with the NMDA receptor. J Neurosci. 25:1826-1835.
76. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. 1994. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:529-540.
77. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH. 1992. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 256:1217-1221.
78. Mueller HT, Meador-Woodruff JH. 2004. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr Res. 71:361-370.
79. Mueller HT, Meador-Woodruff JH. 2005. Distribution of the NMDA receptor NR3A subunit in the adult pig-tail macaque brain. J Chem Neuroanat. 29:157-172.
80. Murphy KM, Beston BR, Boley PM, Jones DG. 2005. Development of human visual cortex: a balance between excitatory and inhibitory plasticity mechanisms. Dev Psychobiol. 46:209-221.
81. O'Connor JA, Hasenkamp W, Horman BM, Muly EC, Hemby SE. 2006. Region specific regulation of NR1 in rhesus monkeys following chronic antipsychotic drug administration. Biol Psychiatry. 60:659-662.
82. Offenhauser N, Castelletti D, Mapelli L, Soppo BE, Regondi MC, Rossi P, D'Angelo E, Frassoni C, Amadeo A, Tocchetti A, et al. 2006. Increased ethanol resistance and consumption in Eps8 knockout mice correlates with altered actin dynamics. Cell. 127:213-226.
83. Olney JW, Newcomer JW, Farber NB. 1999. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res. 33:523-533.
84. Ontl T, Xing Y, Bai L, Kennedy E, Nelson S, Wakeman M, Magnusson K. 2004. Development and aging of N-methyl-D-aspartate receptor expression in the prefrontal/frontal cortex of mice. Neuroscience. 123:467-479.
85. Ossowska K, Pietraszek M, Wardas J, Nowak G, Wolfarth S. 1999. Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats. Naunyn Schmiedebergs Arch Pharmacol. 359:280-287.
86. Ossowska K, Pietraszek M, Wardas J, Nowak G, Zajaczkowski W, Wolfarth S, Pilc A. 2000. The role of glutamate receptors in antipsychotic drug action. Amino Acids. 19:87-94.
87. Pawlak R, Melchor JP, Matys T, Skrzypiec AE, Strickland S. 2005. Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. Proc Natl Acad Sci USA. 102:443-448.
88. Perez-Otano I, Ehlers MD. 2004. Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses. Neurosignals. 13:175-189.
89. Perez-Otano I, Lujan R, Tavalin SJ, Plomann M, Modregger J, Liu XB, Jones EG, Heinemann SF, Lo DC, Ehlers MD. 2006. Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1/syndapin1. Nat Neurosci. 9:611-621.
90. Perez-Otano I, Schulteis CT, Contractor A, Lipton SA, Trimmer JS, Sucher NJ, Heinemann SF. 2001. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci. 21:1228-1237.
91. Petralia RS, Sans N, Wang YX, Wenthold RJ. 2005. Ontogeny of postsynaptic density proteins at glutamatergic synapses. Mol Cell Neurosci. 29:436-452.
92. Philpot BD, Weisberg MP, Ramos MS, Sawtell NB, Tang YP, Tsien JZ, Bear MF. 2001. Effect of transgenic overexpression of NR2B on NMDA receptor function and synaptic plasticity in visual cortex. Neuropharmacology. 41:762-770.
93. Plitzko D, Rumpel S, Gottmann K. 2001. Insulin promotes functional induction of silent synapses in differentiating rat neocortical neurons. Eur J Neurosci. 14:1412-1415.
94. Prybylowski KL, Wolfe BB. 2000. Developmental differences in alternative splicing of the NR1 protein in rat cortex and cerebellum. Brain Res Dev Brain Res. 123:143-150.
95. Quinlan EM, Philpot BD, Huganir RL, Bear MF. 1999. Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo. Nat Neurosci. 2:352-357.
96. Rakic P, Bourgeois JP, Eckenhoff MF, Zecevic N, Goldman-Rakic PS. 1986. Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science. 232:232-235.
97. Ritter LM, Vazquez DM, Meador-Woodruff JH. 2002. Ontogeny of ionotropic glutamate receptor subunit expression in the rat hippocampus. Brain Res Dev Brain Res. 139:227-236.
98. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. 2006. Neurobiology of schizophrenia. Neuron. 52:139-153.
99. Rumpel S, Hatt H, Gottmann K. 1998. Silent synapses in the developing rat visual cortex: evidence for postsynaptic expression of synaptic plasticity. J Neurosci. 18:8863-8874.
100. Salimi K, Glantz LA, Hamer RM, German TT, Gilmore JH, Jarskog LF. 2008. Regulation of complexin 1 and complexin 2 in the developing human prefrontal cortex. Synapse. 62(4):273-282.
101. Sans NA, Montcouquiol ME, Raymond J. 2000. Postnatal developmental changes in AMPA and NMDA receptors in the rat vestibular nuclei. Brain Res Dev Brain Res. 123:41-52.
102. Sasaki YF, Rothe T, Premkumar LS, Das S, Cui J, Talantova MV, Wong HK, Gong X, Chan SF, Zhang D, et al. 2002. Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol. 87:2052-2063.
103. Scherzer CR, Landwehrmeyer GB, Kerner JA, Counihan TJ, Kosinski CM, Standaert DG, Daggett LP, Velicelebi G, Penney JB, Young AB. 1998. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex. J Comp Neurol. 390:75-90.
104. Schmitt A, Zink M, Muller B, May B, Herb A, Jatzko A, Braus DF, Henn FA. 2003. Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits. Neurochem Res. 28:235-241.
105. Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY. 1994. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature. 368:144-147.
106. Shi Y, Schlenker EH. 2002. Neonatal sex steroids affect ventilatory responses to aspartic acid and NMDA receptor subunit 1 in rats. J Appl Physiol. 92:2457-2466.
107. Siegel SJ, Brose N, Janssen WG, Gasic GP, Jahn R, Heinemann SF, Morrison JH. 1994. Regional, cellular, and ultrastructural distribution of N-methyl-D-aspartate receptor subunit 1 in monkey hippocampus. Proc Natl Acad Sci USA. 91:564-568.
108. Siegel SJ, Janssen WG, Tullai JW, Rogers SW, Moran T, Heinemann SF, Morrison JH. 1995. Distribution of the excitatory amino acid receptor subunits GluR2(4) in monkey hippocampus and colocalization with subunits GluR5-7 and NMDAR1. J Neurosci. 15:2707-2719.
109. Stepulak A, Sifringer M, Rzeski W, Endesfelder S, Gratopp A, Pohl EE, Bittigau P, Felderhoff-Mueser U, Kaindl AM, Buhrer C, et al. 2005. NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci USA. 102:15605-15610.
110. Stocca G, Vicini S. 1998. Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J Physiol (Lond). 507:13-24.
111. Sucher NJ, Akbarian S, Chi CL, Leclerc CL, Awobuluyi M, Deitcher DL, Wu MK, Yuan JP, Jones EG, Lipton SA. 1995. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J Neurosci. 15:6509-6520.
112. Sucher NJ, Kohler K, Tenneti L, Wong HK, Grunder T, Fauser S, Wheeler-Schilling T, Nakanishi N, Lipton SA, Guenther E. 2003. N-methyl-D-aspartate receptor subunit NR3A in the retina: developmental expression, cellular localization, and functional aspects. Invest Ophthalmol Vis Sci. 44:4451-4456.
113. Sun L, Margolis FL, Shipley MT, Lidow MS. 1998. Identification of a long variant of mRNA encoding the NR3 subunit of the NMDA receptor: its regional distribution and developmental expression in the rat brain. FEBS Lett. 441:392-396.
114. Sun L, Shipley MT, Lidow MS. 2000. Expression of NR1, NR2A-D, and NR3 subunits of the NMDA receptor in the cerebral cortex and olfactory bulb of adult rat. Synapse. 35:212-221.
115. Swerdlow NR, Auerbach P, Monroe SM, Hartston H, Geyer MA, Braff DL. 1993. Men are more inhibited than women by weak prepulses. Biol Psychiatry. 34:253-260.
116. Talbot K, Cho DS, Ong WY, Benson MA, Han LY, Kazi HA, Kamins J, Hahn CG, Blake DJ, Arnold SE. 2006. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum Mol Genet. 15:3041-3054.
117. Tamminga CA. 1998. Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol. 12:21-36.
118. VanDongen AM, VanDongen HM. 2004. Effects of mRNA untranslated regions on translational efficiency of NMDA receptor subunits. Neurosignals. 13:194-206.
119. Wang Y, TesFaye E, Yasuda RP, Mash DC, Armstrong DM, Wolfe BB. 2000. Effects of post-mortem delay on subunits of ionotropic glutamate receptors in human brain. Brain Res Mol Brain Res. 80:123-131.
120. Watanabe M, Inoue Y, Sakimura K, Mishina M. 1992. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport. 3:1138-1140.
121. Watanabe M, Inoue Y, Sakimura K, Mishina M. 1993. Distinct spatiotemporal distributions of the NMDA receptor channel subunit mRNAs in the brain. Ann N Y Acad Sci. 707:463-466.
122. Waxman EA, Lynch DR. 2005. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist. 11:37-49.
123. Webb SJ, Monk CS, Nelson CA. 2001. Mechanisms of postnatal neurobiological development: implications for human development. Dev Neuropsychol. 19:147-171.
124. Weickert CS, Weinberger DR. 1998. A candidate molecule approach to defining developmental pathology in schizophrenia. Schizophr Bull. 24:303-316.
125. Welch JM, Lu J, Rodriguiz RM, Trotta NC, Peca J, Ding JD, Feliciano C, Chen M, Adams JP, Luo J, et al. 2007. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature. 448:894-900.
126. Wong HK, Liu XB, Matos MF, Chan SF, Perez-Otano I, Boysen M, Cui J, Nakanishi N, Trimmer JS, Jones EG, et al. 2002. Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain. J Comp Neurol. 450:303-317.
127. Wood MW, VanDongen HM, VanDongen AM. 1995. Structural conservation of ion conduction pathways in K channels and glutamate receptors. Proc Natl Acad Sci USA. 92:4882-4886.
128. Wu G-Y, Malinow R, Cline HT. 1996. Maturation of a central glutamatergic synapse. Science. 274:972-976.
129. Yashiro K, Corlew R, Philpot BD. 2005. Visual deprivation modifies both presynaptic glutamate release and the composition of perisynaptic/extrasynaptic NMDA receptors in adult visual cortex. J Neurosci. 25:11684-11692.
130. Zhong J, Carrozza DP, Williams K, Pritchett DB, Molinoff PB. 1995. Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J Neurochem. 64:531-539.
131. Zhu JJ, Esteban JA, Hayashi Y, Malinow R. 2000. Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat Neurosci. 3:1098-1106.
132. Zukin RS, Bennett MV. 1995. Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci. 18:306-313.